Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Aug;45(8):1114-1116.
doi: 10.1007/s00270-022-03172-5. Epub 2022 Jun 2.

Comment on: A Systematic Review and Meta-analysis of Patient Survival and Disease Recurrence Following Percutaneous Ablation of Pulmonary Metastasis

Affiliations
Comment

Comment on: A Systematic Review and Meta-analysis of Patient Survival and Disease Recurrence Following Percutaneous Ablation of Pulmonary Metastasis

Fergus Macbeth et al. Cardiovasc Intervent Radiol. 2022 Aug.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Nguyenhuy M, Xu Y, Maingard J, Barnett S, Kok HK, Brooks M, et al. A systematic review and meta-analysis of patient survival and disease recurrence following percutaneous ablation of pulmonary metastasis. Cardiovasc Intervent Radiol. 2022. https://doi.org/10.1007/s00270-022-03116-z . - DOI - PubMed
    1. Milosevic M, Edwards J, Tsang D, Dunning J, Shackcloth M, Batchelor T, et al. Pulmonary Metastasectomy in Colorectal Cancer: updated analysis of 93 randomized patients—control survival is much better than previously assumed. Colorectal Dis. 2020;22(10):1314–24. - DOI
    1. Treasure T, Farewell V, Macbeth F, Batchelor T, Milosevic M, King J, et al. The Pulmonary Metastasectomy in Colorectal Cancer cohort study: analysis of case selection, risk factors and survival in a prospective observational study of 512 patients. Colorectal Dis. 2021;23(7):1793–803. - DOI
    1. Macbeth F, Farewell V, Treasure T. RE: Local treatment of unresectable colorectal liver metastases: results of a randomized phase II trial. J Natl Cancer Inst. 2017;109(10):29117361. https://doi.org/10.1093/jnci/djx149 . - DOI
    1. Macbeth F, Treasure T. Points to consider regarding the SABR-COMET trial. Lancet. 2020;395(10222):e19. - DOI

LinkOut - more resources